SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Immunosyn Corp – ‘SB-2’ on 10/6/06 – EX-5.1

On:  Friday, 10/6/06, at 4:40pm ET   ·   Accession #:  950123-6-12394   ·   File #:  333-137881

Previous ‘SB-2’:  None   ·   Next:  ‘SB-2/A’ on 11/3/06   ·   Latest:  ‘SB-2/A’ on 12/22/06

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of                Filer                Filing    For·On·As Docs:Size              Issuer               Agent

10/06/06  Immunosyn Corp                    SB-2                   8:599K                                   RR Donnelley/FA

Registration of Securities by a Small-Business Issuer   —   Form SB-2
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: SB-2        Registration of Securities by a Small-Business      HTML    300K 
                          Issuer                                                 
 2: EX-3.1      Ex-3.1: Certificate of Incorporation                HTML     22K 
 3: EX-3.2      Ex-3.2: Bylaws                                      HTML     42K 
 4: EX-5.1      Ex-5.1: Opinion of Brown Raysman Millstein Felder   HTML     11K 
                          & Steiner LLP                                          
 5: EX-10.1     Ex-10.1: License Agreement                          HTML    109K 
 6: EX-10.2     Ex-10.2: Form of Lock-Up Agreement                  HTML     17K 
 7: EX-10.3     Ex-10.3: 2006 Stock Option Plan                     HTML     74K 
 8: EX-23.1     Ex-23.1: Consent of Malone & Bailey, Pc             HTML      7K 


EX-5.1   —   Ex-5.1: Opinion of Brown Raysman Millstein Felder & Steiner LLP


This exhibit is an HTML Document rendered as filed.  [ Alternative Formats ]



  EX-5.1  

 

Exhibit 5.1
(BROWN RAYSMAN LOGO)
 
 
          October 6, 2006
 
 
The Board of Directors
Immunosyn Corporation
4225 Executive Square
Suite 260
La Jolla, California 92037
Re: Immunosyn Corporation — Registration Statement on Form SB-2
Ladies and Gentlemen:
We have acted as counsel to Immunosyn Corporation (the “Company”) in connection with the registration for resale under the Securities Act of 1933, as amended (the “Act”), of 277,000,000 shares (the “Shares”) of its common stock, $.0001 par value per share (“Common Stock”), to be sold by certain selling stockholders pursuant to a Registration Statement on Form SB-2 (the “Registration Statement”), and certain matters relating thereto.
In that connection, we have examined such documents, corporate records and other instruments and undertaken such further inquiry as we have deemed necessary or appropriate for purposes of this opinion, including, but not limited to, examination of the Registration Statement and the Certificate of Incorporation and Bylaws of the Company, including all amendments thereto. In our examination, we have assumed the genuineness of all signatures, the legal capacity of all natural persons, the accuracy and completeness of all documents submitted to us, the authenticity of all original documents, and the conformity to authentic original documents of all documents submitted to us as copies (including telecopies). This opinion letter is given, and all statements herein are made, in the context of the foregoing.
Based upon, subject to and limited by the foregoing and the other qualifications and limitations stated in this letter, we are of the opinion that the Shares being registered for resale by existing stockholders are duly authorized, validly issued, fully paid and non-assessable Shares of the Company in the control of their present owners, and will remain fully paid when resold by those stockholders.
This opinion is limited to the laws of the State of Delaware and the federal law of the United States of America and to the matters stated herein. This opinion is made as of the date hereof, and after the date hereof, we undertake no, and disclaim any, obligation to advise you of any change in any matters set forth herein.
(BROWN RAYSMAN FOOTER)

 



 

We do not express an opinion on any matters other than those expressly set forth in this letter.
             
 
           
    Very truly yours,    
 
           
 
           
 
  /s/   Brown Raysman Millstein Felder & Steiner LLP    

 


Dates Referenced Herein

This ‘SB-2’ Filing    Date    Other Filings
Filed on:10/6/06None on these Dates
 List all Filings 
Top
Filing Submission 0000950123-06-012394   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Mon., Apr. 29, 9:48:05.1am ET